Top Markets
Coin of the day
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO
Clasificación en acciones #91
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical... Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Precio por acción
$475.89
Capitalización bursátil
$176.79B
Cambio (1 día)
-4.00%
Cambio (1 año)
-7.17%
País
US
Comercio Thermo Fisher Scientific Inc. (TMO)

Categoría

Ratio P/E de Thermo Fisher Scientific Inc. (TMO)
Ratio P/E al March 2026 TTM: 29.18
Según los últimos informes financieros y el precio de las acciones de Thermo Fisher Scientific Inc., el P/E actual (TTM) de la empresa es 29.18. Al final de 2024, la empresa tenía un P/E de 31.37.
Historial del ratio P/E de Thermo Fisher Scientific Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) 29.18 -9.77%
2025 32.34 3.09%
2024 31.37 -8.21%
2023 34.18 10.03%
2022 31.06 -8.73%
2021 34.03 17.62%
2020 28.93 -17.71%
2019 35.16 14.82%
2018 30.62 -9.16%
2017 33.71 22.34%
2016 27.55 -3.76%
2015 28.63 8.71%
2014 26.34 -16.42%
2013 31.51 59.95%
2012 19.70 52.98%
2011 12.88 -40.27%
2010 21.56 -6.79%
2009 23.13 61.40%
2008 14.33 -55.14%
2007 31.94 -39.24%
2006 52.57 141.04%
2005 21.81 60.24%
2004 13.61 -33.61%
2003 20.50 88.61%
2002 10.87 -100.20%
2001 -5.50K 4,633.22%
2000 -116.27 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
41.22 41.28%
US
49.65 70.15%
US
18.53 -36.50%
CN
26.63 -8.74%
US
22.35 -23.40%
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.